BAKER BROS ADVISORS LLC Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2018 | NVTA | Invitae Corp | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 4.50 | 999,514 | 4,497,813 | 7,480,182 | 6.5 M to 7.5 M (+15.42 %) |
| Mar 29 2018 | NVTA | Invitae Corp | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 4.50 | 111,597 | 502,187 | 845,858 | 734.3 K to 845.9 K (+15.20 %) |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 439,036 | 206,347 | 0 | |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 17,626,445 | 8,284,429 | 0 | |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 2,250,846 | 1,057,898 | 0 | |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 439,036 | 206,347 | 602,867 | 163.8 K to 602.9 K (+267.98 %) |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 17,626,445 | 8,284,429 | 34,193,251 | 16.6 M to 34.2 M (+106.40 %) |
| Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 2,250,846 | 1,057,898 | 4,102,796 | 1.9 M to 4.1 M (+121.54 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 338,947 | 330.7 K to 338.9 K (+2.49 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 11,369,282 | 11.4 M to 11.4 M (+0.07 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 1,778,613 | 1.8 M to 1.8 M (+0.47 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 52,339 | 44.1 K to 52.3 K (+18.71 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 212,998 | 204.7 K to 213 K (+4.03 %) |
| Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 233,262 | 225 K to 233.3 K (+3.67 %) |